NCT02964442

Brief Summary

Brown adipose tissue (BAT) thermogenesis can be assessed by IR thermography, the accompanying increase metabolic rate can be measured by whole body calorimetry and BAT volume can be precisely measured by MRI. The aim of the study is to validate IRT for BAT thermogenesis against the present gold standard 18-FDG-PET scan, quantify BAT volume by fat fraction MRI and measure the accompanying increase in BMR by whole body calorimetry among healthy euthyroid subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2015

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

November 4, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 16, 2016

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 24, 2023

Completed
Last Updated

May 10, 2024

Status Verified

May 1, 2024

Enrollment Period

8 years

First QC Date

November 4, 2016

Last Update Submit

May 9, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Brown adipose tissue activation detection by Imaging using 18-FDG-PET/ MRI.

    post consumption of capsinoids capsules for 2 hours

  • Energy Expenditure using Whole Body Calorimeter.

    post consumption of capsinoids capsules for 2 hours

  • Brown adipose tissue activation detection by Imaging using Infrared Thermography.

    post consumption of capsinoids capsules for 2 hours

Secondary Outcomes (3)

  • Brown adipose tissue activation detection by Imaging using 18-FDG-PET/ MRI.

    post cold stimulus up to 2 hours

  • Energy Expenditure using Whole Body Calorimeter.

    To measure cold stimulus for 2 hours

  • Brown adipose tissue activation detection by Imaging using Infrared Thermography.

    post cold stimulus up to 2 hours

Study Arms (2)

Capsinoids

EXPERIMENTAL

8 gel capsules equivalent to 12mg

Other: Capsinoids

Cooling Vest

EXPERIMENTAL

Using Cooling vest (at approxiamately14 degrees Celsius) to cool the body.

Other: Cold Stimulus

Interventions

12 mg of Gel capsules

Capsinoids

Cooling vest maintain at 14 degree Celsius

Cooling Vest

Eligibility Criteria

Age21 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Overtly healthy with no past history of chronic illnesses
  • Aged 21-40 years old Male and female gender
  • BMI from 18.5 to 29.9 kg/m2 inclusive
  • No prior history of thyroid disease.
  • Euthyroid biochemically with FT4 and TSH in the normal ranges

You may not qualify if:

  • Recent changes in weight of \>5% over the past 6 months.
  • Attempts to lose weight over the past 6 months.
  • Significant changes in diet over the past 6 months.
  • Any use of weight reducing drugs in the past 6 months.
  • Previous weight reducing surgery.
  • Any use of investigational drugs in the past 6 months.
  • Subclinical thyroid dysfunction based on thyroid function test.
  • Chronic illnesses such as diabetes mellitus or cancer.
  • You have a known history of thyroid, liver or kidney disease.
  • Use of any prescription medication that cannot be safely discontinued within 14 days prior to study entry.
  • Female subjects who are pregnant.
  • Oral medications affecting brown fat activity (eg. alpha agonists or blockers, beta agonists or blockers, sympatholytic agents) which the researchers will clarify with you.
  • Chronic topical ointment with menthol or capsaicin or use of nasal decongestants.
  • History of surgery with metallic clips, staples or stents.
  • Presence of cardiac pacemaker or other foreign body in any part of the body.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Nutrition Research Centre

Singapore, 117599, Singapore

Location

Related Publications (3)

  • Sun L, Yan J, Goh HJ, Govindharajulu P, Verma S, Michael N, Sadananthan SA, Henry CJ, Velan SS, Leow MK. Fibroblast Growth Factor-21, Leptin, and Adiponectin Responses to Acute Cold-Induced Brown Adipose Tissue Activation. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e520-31. doi: 10.1210/clinem/dgaa005.

  • Sun L, Verma S, Michael N, Chan SP, Yan J, Sadananthan SA, Camps SG, Goh HJ, Govindharajulu P, Totman J, Townsend D, Goh JP, Sun L, Boehm BO, Lim SC, Sze SK, Henry CJ, Hu HH, Velan SS, Leow MK. Brown Adipose Tissue: Multimodality Evaluation by PET, MRI, Infrared Thermography, and Whole-Body Calorimetry (TACTICAL-II). Obesity (Silver Spring). 2019 Sep;27(9):1434-1442. doi: 10.1002/oby.22560. Epub 2019 Jul 13.

  • Sun L, Camps SG, Goh HJ, Govindharajulu P, Schaefferkoetter JD, Townsend DW, Verma SK, Velan SS, Sun L, Sze SK, Lim SC, Boehm BO, Henry CJ, Leow MK. Capsinoids activate brown adipose tissue (BAT) with increased energy expenditure associated with subthreshold 18-fluorine fluorodeoxyglucose uptake in BAT-positive humans confirmed by positron emission tomography scan. Am J Clin Nutr. 2018 Jan 1;107(1):62-70. doi: 10.1093/ajcn/nqx025.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 4, 2016

First Posted

November 16, 2016

Study Start

October 23, 2015

Primary Completion

October 24, 2023

Study Completion

October 24, 2023

Last Updated

May 10, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations